Non-emergency telecardiology consultation services: rapid review of clinical and cost outcomes
Murphy G, Prichett-Pejic W, Severn M
Record ID 32010001767
English
Authors' recommendations:
Overall, the quantity and quality of studies comparing telecardiology consultation programs to usual care were low. In many studies, the patients in the telehealth and control groups were not equivalent, raising concerns about selection bias. One study was conducted in Canada, and the generalizability of the findings of economic studies that are conducted outside Canada is limited.The literature suggests that the implementation of clinic- or hospital-based telecardiology programs is feasible in communities with limited access to cardiovascular specialists. Because of the limitations of the evidence, conclusions about diagnostic accuracy or impact on patient outcomes cannot be made.Telecardiology programs reduce the number of patients who are required to travel to access care. This may reduce the travel costs of patients or health care payers. The cost of telecardiology programs is affected by the volume of patients using the service, with higher volumes reducing the per-patient cost of acquiring and operating telemedicine equipment.None of the studies reported on wait times, and limited information was available on patient satisfaction with telecardiology programs. There is limited evidence available to guide decision-makers planning to implement telecardiology consultation services in their jurisdiction.
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/H0501_Telecardiology_Report_e.pdf
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Arrhythmias, Cardiac
- Cardiology Service, Hospital
- Cost-Benefit Analysis
- Diagnosis, Computer-Assisted
- Remote Consultation
- Telemedicine
- Telephone
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.